Effects of Dietary Natural Compounds on DNA Methylation Related to Cancer Chemoprevention and Anticancer Epigenetic Therapy

Epigenetics and Human Health: Linking Hereditary, Environmental and Nutritional Aspects

Volumn , Issue , 2010, Pages 141-155

  Stefanska, Barbara Maria ^a   Fabianowska Majewska, Krystyna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Bioflavonoids; Cancer chemoprevention; Catechins; DNA methylation; Phytoestrogens; Vitamins

Indexed keywords

EID: 84884658250     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527628384.ch11     Document Type: Chapter

References (61)

1. Jones, P.A., and Baylin, S.B. (2007) The epigenomics of cancer. Cell, 128, 683-692.
2. Szyf, M. (2005) DNA methylation and demethylation as targets for anticancer therapy. Biochem. (Moscow), 70, 651-669.
3. Szyf, M., Pakneshan, P., and Rabbani, S.A. (2004) DNA methylation and breast cancer. Biochem. Pharmacol., 68, 1187-1197.
4. Balch, C., Montgomery, J.S., Paik, H.-I., Kim, S., Huang, T.H.-M., and Nephew, K.P. (2005) New anti-cancer strategies: epigenetic therapies and biomarkers. Front. Biosci., 10, 1897-1931.
5. Fang, M., Chen, D., and Yang, C.S. (2007) Dietary polyphenols may affect DNA methylation. J. Nutr., 137, 223S-228S.
6. Fang, M.Z., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W., and Yang, C.S. (2003) Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer. Res., 63, 7563-7570.
7. Lee, W.J., Shim, J.-Y., and Zhu, B.T. (2005) Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol., 68, 1018-1030.
8. Lee, W.J., and Zhu, B.T. (2006) Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis, 27, 269-277.
9. Krawczyk, B., and Fabianowska-Majewska, K. (2006) Alteration of promoter methylation of selected tumor suppressor genes by adenosine analogs in combination with natural compounds in MCF-7 cells. Proceedings of the Free Papers, UICC World Cancer Congress, Washington. pp. 53-56.
10. Krawczyk, B., Rudnicka, K., and Fabianowska-Majewska, K. (2007) Effects of nucleoside analogues on promoter methylation status of selected tumour suppressor genes in MCF-7 and MDA-MB-231 breast cancer cell lines. Nucleosides Nucleotides Nucleic Acids, 26, 1043-1046.
11. Bigey, P., Ramchandani, S., Theberge, J., Araujo, F.D., and Szyf, M. (2000) Transcriptional regulation of the human DNA methyltransferase (dnmt1) gene. Gene., 242, 407-418.
12. Hermann, A., Gowher, H., and Jeltsch, A. (2004) Biochemistry and biology of mammalian DNA methyltransferases. Cell. Mol. Life. Sci., 61, 2571-2587.
13. Paluszczak, J., and Baer-Dubowska, W. (2006) Epigenetic diagnostics of cancer-the application of DNA methylation markers. J. Appl. Genet., 47, 365-375.
14. Girault, I., Tozlu, S., Lidereau, R., and Bièche, I. (2003) Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Clin. Cancer Res., 9, 4415-4422.
15. Xiong, Y., Dowdy, S.C., Xue, A., Shujuan, J., Eberhardt, N.L., Pedratz, K.C., and Jiang, S.-W. (2005) Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. Gynecol. Oncol., 96, 601-609.
16. Patra, S.K., Patra, A., Zhao, H., and Dahiya, R. (2002) DNA methyltransferase and demethylase in human prostate cancer. Mol. Carcinog., 33, 163-171.
17. Oh, B.K., Kim, H., Park, H.J., Shim, Y.H., Choi, J., Park, C., and Park, Y.N. (2007) DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Int. J. Mol. Med., 20, 65-73.
18. Wang, Q., Lee, D., Sysounthone, V., Chandraratna, R.A.S., Christakos, S., Korah, R., and Wieder, R. (2001) 1,25-dihydroxyvitamin D 3 and retinoic acid analogues induce differentiation in breast cancer cells with function-and cell-specific additive effects. Breast Cancer Res. Treat., 67, 157-168.
19. Pozo-Guisado, E., Alvarez-Barrientos, A., Mulero-Navarro, S., Santiago-Josefat, B., and Fernandez-Salguero, P.M. (2002) The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not in MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem. Pharmacol., 64, 1375-1386.
20. Pozo-Guisado, E., Lorenzo-Benayas, J., and Fernandez-Salguero, P.M. (2004) Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor α-dependent mechanism: relevance in cell proliferation. Int. J. Cancer, 109, 167-173.
21. Murray, R.K., Granner, D.K., Mayes, P.A., and Rodwell, V.W. (eds) (1995) Harper ' s Biochemistry, PZWL, Warsaw, pp. 1-955.
22. Baer-Dubowska, W. (2003) Chemoprevetion-prophylaxis and adjuvant therapy of head and neck cancers. Postepy w chirurgii glowy i szyi, 2, 3-14.
23. Fujii, T., Yokoyama, G., Takahashi, H., Namoto, R., Nakagawa, S., Toh, U., Kage, M., Shirouzu, K., and Kuwano, M. (2008) Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer. Breast Cancer, 15, 73-78.
24. Welsh, J., Wietzke, J.A., Zinser, G.M., Byrne, B., Smith, K., and Narvaez, C.J. (2003) Vitamin D-3 receptor as a target for breast cancer prevention. J. Nutr., 133, 2425S-2433S.
25. Shin, M.J., Holmes, M.D., Hankinson, S.E., Wu, K., Colditz, G.A., and Willet, W.C. (2002) Intake of dairy products, calcium and vitamin D and risk of breast cancer. J. Natl. Cancer Inst., 94, 1301-1310.
26. Grant, W.B. (2002) An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer, 94, 272-281.
27. Le Corre, L., Fustier, P., Chalabi, N., Bignon, Y.J., and Bernard-Gallon, D. (2004) Effects of resveratrol on the expression of a panel of genes interacting with the BRCA1 oncosuppressor in human breast cell lines. Clin. Chim. Acta., 344, 115-121.
28. Bowers, J.L., Tyulmenkov, V.V., Jernigan, S.C., and Klinge, C.M. (2000) Resveratrol acts as a mixed agonist/antagonist for oestrogen receptors alpha and beta. Endocrinology, 141, 3657-3667.
29. Cornwell, T., Cohick, W., and Raskin, I. (2004) Dietary phytoestrogens and health. Phytochem., 65, 995-1016.
30. Whitsett, T.G. Jr., and Lamartiniere, C.A. (2006) Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat. Expert. Rev. Anticancer Ther., 6, 1699-1706.
31. Raynal, N.J.-M., Momparler, L., Charbonneau, M., and Momparler, R.L. (2008) Antileukemic activity of genistein, a major isoflavone present in soy products. J. Nat. Prod., 71, 3-7.
32. Shen, J., Tai, Y.C., Zhou, J., Stephen Wong, C.H., Cheang, P.T., Wong, W.S., Xie, Z., Khan, M., Han, J.H., and Chen, C.S. (2007) Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signalling. Exp. Hematol., 35, 75-83.
33. Cabanes, A., Wang, M., Olivo, S., DeAssis, S., Gustafsson, J.A., Khan, G., and Hilakivi-Clarke, L. (2004) Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis, 25, 741-748.
34. Arai, N., Strom, A., Rafter, J.J., and Gustafsson, J.A. (2000) Estrogen receptor β mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem. Biophys. Res. Commun., 270, 425-431.
35. Fang, M.Z., Chen, D., Sun, Y., Jin, Z., Christman, J.K., and Yang, C.S. (2005) Reversal of hypermethylation and reactivation of p16 INK4a, RAR, and MGMT genes by genistein and other isoflavones from soy. Clin. Cancer. Res., 11, 7033-7041.
36. Iida, T., Suetake, I., Tajima, S., Morioka, H., Ohta, S., Obuse, C., and Tsurimoto, T. (2002) PCNA clamp facilitates action of DNA cytosine methyltransferase 1 on hemimethylated DNA. Genes. Cells, 7, 997-1007.
37. Milutinovic, S., Knox, J.D., and Szyf, M. (2000) DNA methyltransferase inhibition induces the transcription of the tumor suppressor p21 WAF1/CIP1/sdi1. J. Biol. Chem., 275, 6353-6359.
38. Milutinovic, S., Brown, S.E., Zhuang, Q., and Szyf, M. (2004) DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation. J. Biol. Chem., 279, 27915-27927.
39. Kimura, H., Nakamura, T., Ogawa, T., Tanaka, S., and Shiota, K. (2003) Transcription of mouse DNA methyltransferase 1 (Dnmt1) is regulated by both E2F-Rb-HDAC-dependent and-independent pathways. Nucleic. Acids. Res., 31, 3101-3113.
40. McCabe, M.T., Davis, J.N., and Day, M.L. (2005) Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Res., 65, 3624-3632.
41. Robertson, K.D., Ait-Si-Ali, S., Yokochi, T., Wade, P.A., Jones, P.L., and Wolffe, A.P. (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet., 25, 338-342.
42. Agoston, A.T., Argani, P., De Marzo, A.M., Hicks, J.L., and Nelson, W.G. (2007) Retinoblastoma pathway dysregulation causes DNA methyltransferase 1 overexpression in cancer via MAD2-mediated inhibition of the anaphase-promoting complex. Am. J. Pathol., 170, 1585-1593.
43. Pratt, M.A., Niu, M., and White, D. (2003) Differential regulation of protein expression, growth and apoptosis by natural and synthetic retinoids. J. Cell. Biochem., 90, 692-708.
44. Wu, Q., Chen, Z., and Su, W. (2001) Growth inhibition of gastric cancer cells by all-trans retinoic acid through arresting cell cycle progression. Chin. Med. J. (Engl.), 114, 958-961.
45. Hager, G., Kornfehl, B., Weigel, G., and Formanek, M. (2004) Molecular analysis of p21 promoter activity isolated from squamous carcinoma cell lines of the head and neck under the influence of 1,25(OH)2 vitamin D 3 and its analogs. Acta. Otolaryngol., 124, 90-96.
46. Arany, I., Whitehead, W.E., Ember, I.A., and Tybing, S.K. (2003) Dose-dependent activation of p21WAF1 transcription by all-trans-acid in cervical squamous carcinoma cells. Anticancer Res, 23, 495-497.
47. Ismail, I.A., Kang, K.S., Lee, H.A., Kim, J.W., and Sohn, Y.K. (2007) Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation. Eur. J. Pharmacol., 575, 12-20.
48. Bakin, A.V., and Curran, T. (1999) Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science., 283, 387-390.
49. Chuang, J.H., Ostrowski, M.C., Romigh, T., Minaguchi, T., Waite, K.A., and Eng, C. (2006) The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation. Hum. Mol. Genet., 15, 2553-2559.
50. Krawczyk, B., Rychlewski, P., and Fabianowska-Majewska, K. (2006) PTEN-tumour suppressor protein: regulation of protein activity and gene expression. Postepy. Biologii. Komorki., 33, 365-380.
51. Pethe, V., and Shekhar, P.V.M. (1999) Estrogen inducibility of c-Ha-ras transcription in breast cancer cells. Identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron 1 of the c-Ha-ras gene. J. Biol. Chem., 274, 30969-30978.
52. Hisatake, J., O ' Kelly, J., Uskokovic, M.R., Tomoyasu, S., and Koeffler, H.P. (2001) Novel vitamin D 3 analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D 3, that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells. Blood, 97, 2427-2433.
53. Zhou, X.-F., Shen, X.-Q., and Shemshedini, L. (1999) Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization. Mol. Endocrinol., 13, 276-285.
54. Swami, S., Krishnan, A.V., and Feldman, D. (2000) 1 α,25-dihydroxyvitamin D 3 down-regulates estrogen receptor abundance and suppresses estrogen action in MCF-7 human breast cancer cells. Clin. Cancer Res., 6, 3371-3379.
55. Waite, K.A., Sinden, M.R., and Eng, C. (2005) Phytoestrogen exposure elevates PTEN levels. Hum. Mol. Genet., 14, 1457-1463.
56. Gong, L., Li, Y., Nedeljkovic-Kurepa, A., and Sarkar, F.H. (2003) Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene., 22, 4702-4709.
57. Yu, R., Hebbar, V., Kim, D.W., Mandlekar, S., Pezzuto, J.M., and Kong, A.N. (2001) Resveratrol inhibits phorbol ester and UV-induced activator protein 1 activation by interfering with mitogen-activated protein kinase pathways. Mol. Pharmacol., 60, 217-224.
58. Lu, Q., Qiu, X., Hu, N., Wen, H., Su, Y., and Richardson, B.C. (2006) Epigentics, disease, and therapeutic intervention. Aging. Res. Rev., 5, 449-467.
59. Nair, S., Li, W., and Kong, A.-N.T. (2007) Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells. Acta. Pharmacol. Sin., 28, 459-472.
60. Ramos, S. (2007) Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J. Nutr. Biochem., 18, 427-442.
61. Tapiero, H., Tew, K.D., Ba, G.N., and Math é, G. (2002) Polyphenols: do they play a role in the prevention of human pathologies? Biomed. Pharm., 56, 200-207.